A pharmaceutical company has volunteered to distribute free Narcan Nasal Spray in all U.S. High Schools in conjunction with Smith Medical Partners in hopes of reducing the number of deaths resulting from opioid overdoses.
Adapt Pharma made the announcement on April 28.
The company released a statement saying that the Nasal Spray, which consist of a drug called naloxone, “is the first and only FDA-approved naloxone nasal spray for the emergency treatment of opioid.”
The sprays “have the ability to help reverse opioid overdose,” Thomas Duddy, Executive Director of communication at Adapt Pharma told Epoch Times.
According to the New England Journal of Medicine, author Kim Jae-Hyung wrote:
“During an opioid overdose, opioid receptors in the respiratory center of the brain are activated. When this occurs, respiratory drive is suppressed and the breathing rate can either slow dangerously or stop completely.
“Rapid reversal of respiratory depression is crucial to help prevent hypoxic brain injury or death.”
